Skip to content

Application of tranexamic acid in arthroscopic rotator cuff repair

Application of tranexamic acid in arthroscopic rotator cuff repair

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060743
Enrollment
Unknown
Registered
2022-06-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tears

Interventions

Tranexamic acid group:Intravenous tranexamic acid
The control group:Intravenous drip of equal amount of normal saline

Sponsors

Sports Medicine Center of the Second Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who received arthroscopic rotator cuff repair in the Sports Medicine Center of the Second Affiliated Hospital of Inner Mongolia Medical University; 2. Patients diagnosed with rotator cuff tear and failed to receive conservative treatment for more than 3 months; 3. Do not have any bleeding disease or coagulation disease, not pregnant or not taking birth control pills; 4. All enrolled patients signed informed consent, which was discussed and approved by the hospital ethics Committee.

Exclusion criteria

Exclusion criteria: 1. Hypertension is not under control (systolic blood pressure > 180 mmHg); Uncontrolled intraoperative hypertension (>180/110 mmHg); 2. Irreparable rotator cuff tear (tear length > 5 cm or tear range > 2 tendons); 3. Patients with acute traumatic rotator cuff tear; 4. Patients with abnormal coagulation function who received anticoagulant therapy before surgery and abnormal coagulation function before surgery (prothrombin time or activated partial thrombin time); 5. Patients with kidney or liver disease or allergy to local anesthetics or TXA; 6. Revision cases.

Design outcomes

Primary

MeasureTime frame
Visual clarity under arthroscopy;

Secondary

MeasureTime frame
Pain;Total operation time;Swelling of the shoulder;

Countries

China

Contacts

Public ContactChangxu Han

The Second Affiliated Hospital of Inner Mongolia Medical University

meniscus2011@163.com+86 15848146364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026